Skip to main content
. 2021 Apr 13;9(6):e841–e853. doi: 10.1016/S2214-109X(21)00045-0

Figure 3.

Figure 3

Prevalence and cumulative incidence of primary and secondary endpoint tuberculosis

Prevalence and cumulative incidence of primary (A) and secondary (B) endpoint tuberculosis in RISK11-positive and RISK11-negative participants at study enrolment and over 15 months of follow-up. Error bars and shaded areas represent the 95% CIs.